Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Heart Rate Variability Analysis in Congestive Heart Failure: The Need for Standardized Assessment Protocols

M. Míková, D. Pospíšil, J. Řehoř, M. Malik

. 2025 ; 26 (5) : 36321. [pub] 20250526

Status neindexováno Jazyk angličtina Země Singapur

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25014302

Heart rate variability (HRV) analysis is a noninvasive tool that allows cardiac autonomic control to be assessed. Numerous studies have reported HRV measurements, related changes, and clinical implications for heart failure patients. This review evaluates HRV characteristics in congestive heart failure (CHF), focusing on different recording durations and the diagnostic and prognostic values using HRV measurements. The recording durations are classified as (a) ultra short-term (substantially shorter than 5 minutes), (b) short-term (5 minutes), and (c) long-term (nominal 24 hours). This review of HRV diagnostic and prognostic significance in CHF focuses on time- and frequency-domain HRV measures that have previously been extensively studied. Reported studies document that HRV is lowered in CHF patients, whereas HRV increases may indicate disease improvement, e.g., in CHF patients undergoing cardiac resynchronization therapy. Reduced HRV has consistently been found to be associated with all-cause mortality in CHF patients. However, different thresholds of long-term HRV indices have been proposed as mortality predictors; meanwhile, findings related to the prediction of other cardiac events, including sudden cardiac death, remain inconsistent. HRV is reduced in CHF patients, but the use of HRV as a risk factor remains controversial, with no established cut-off values. HRV does not provide a clinically useful prediction of sudden cardiac death or other cardiac events in CHF patients. Thus, we advocate standardization of investigative protocols based on the existing time- and frequency-domain HRV indices rather than further developing more complex methods. Short-term recordings are preferable for clinical application and measurement reproducibility; thus, future investigations should focus on the following key questions: 1. How to design standardized short HRV tests suitable for outpatient settings? 2. Which HRV indices should be preferred, and what are their optimal prognostic thresholds? 3. How to standardize HRV assessment conditions to minimize external influences?

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25014302
003      
CZ-PrNML
005      
20250905141416.0
007      
ta
008      
250701s2025 si f 000 0|eng||
009      
AR
024    7_
$a 10.31083/RCM36321 $2 doi
035    __
$a (PubMed)40475734
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a si
100    1_
$a Míková, Monika $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000170401967
245    10
$a Heart Rate Variability Analysis in Congestive Heart Failure: The Need for Standardized Assessment Protocols / $c M. Míková, D. Pospíšil, J. Řehoř, M. Malik
520    9_
$a Heart rate variability (HRV) analysis is a noninvasive tool that allows cardiac autonomic control to be assessed. Numerous studies have reported HRV measurements, related changes, and clinical implications for heart failure patients. This review evaluates HRV characteristics in congestive heart failure (CHF), focusing on different recording durations and the diagnostic and prognostic values using HRV measurements. The recording durations are classified as (a) ultra short-term (substantially shorter than 5 minutes), (b) short-term (5 minutes), and (c) long-term (nominal 24 hours). This review of HRV diagnostic and prognostic significance in CHF focuses on time- and frequency-domain HRV measures that have previously been extensively studied. Reported studies document that HRV is lowered in CHF patients, whereas HRV increases may indicate disease improvement, e.g., in CHF patients undergoing cardiac resynchronization therapy. Reduced HRV has consistently been found to be associated with all-cause mortality in CHF patients. However, different thresholds of long-term HRV indices have been proposed as mortality predictors; meanwhile, findings related to the prediction of other cardiac events, including sudden cardiac death, remain inconsistent. HRV is reduced in CHF patients, but the use of HRV as a risk factor remains controversial, with no established cut-off values. HRV does not provide a clinically useful prediction of sudden cardiac death or other cardiac events in CHF patients. Thus, we advocate standardization of investigative protocols based on the existing time- and frequency-domain HRV indices rather than further developing more complex methods. Short-term recordings are preferable for clinical application and measurement reproducibility; thus, future investigations should focus on the following key questions: 1. How to design standardized short HRV tests suitable for outpatient settings? 2. Which HRV indices should be preferred, and what are their optimal prognostic thresholds? 3. How to standardize HRV assessment conditions to minimize external influences?
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Pospíšil, David $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000261735225
700    1_
$a Řehoř, Jan $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Malik, Marek $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic $u National Heart and Lung Institute, Imperial College, ICTEM Building, Hammersmith Campus, W12 0NN London, UK $1 https://orcid.org/0000000237921407 $7 xx0098959
773    0_
$w MED00203331 $t Reviews in cardiovascular medicine $x 2153-8174 $g Roč. 26, č. 5 (2025), s. 36321
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40475734 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250701 $b ABA008
991    __
$a 20250905141404 $b ABA008
999    __
$a ok $b bmc $g 2388037 $s 1251422
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 26 $c 5 $d 36321 $e 20250526 $i 2153-8174 $m Reviews in cardiovascular medicine $n Rev Cardiovasc Med $x MED00203331
LZP    __
$a Pubmed-20250701

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...